Advanced Filters
noise

Ampelokipi - Athens, Greece Clinical Trials

A listing of Ampelokipi - Athens, Greece clinical trials actively recruiting patients volunteers.

Found 430 clinical trials

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

The main purpose of this study is to determine the safety and efficacy of eltrekibart and mirikizumab in adult participants with moderately to severely active ulcerative colitis (UC).

18 - 75 years of age All Phase 2
E Evaggelismos G Hospital, MD, PhD

Burnout Syndrome in the Intensive Care Unit Before and During a Palliative Care Trial

One hundred ICU doctors, nurses and psychologists from the 28 units participating in the EPIC stepped-wedge trial (ClinicalTrials.gov NCT06605079) will each complete the same four-part survey twice-once during their unit's usual-care phase and again during the EPIC tele-palliative-care intervention. The questionnaire begins with Part A, gathering demographic and professional details …

years of age All Phase N/A
M Michael Georgoulis, PhD

A Study of Chios Mastic Water in Dyspepsia

Chios mastic is a natural product with strong antimicrobial, anti-inflammatory and antioxidant properties, and well-established benefits for dyspeptic disorders. The aim of the present study is to investigate the effectiveness of a natural aqueous extract of Chios mastic (mastic water), a by-product of Chios mastic processing, in the management of …

30 - 60 years of age All Phase N/A
D Dimitrios K Filippiadis, MD, PhD

Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)

To demonstrate that microwave ablation (MWA) of up to 3 hepatic metastases, each with a maximum diameter of ≤ 2.5 cm will result in a 2-year local progression free survival of at least 90%. This is a standard of care (SOC) study.

18 years of age All Phase N/A
A Agni Pantou, M.D

Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders

Autologous PRP intra ovarian infusion may improve ovarian response, patients' hormonal profile as well as fresh embryo transfer (ET)-ICSI cycles' outcome in patients presenting with Poor Ovarian Response (POR).

35 - 47 years of age Female Phase 2/3

Specific Oral Tolerance Induction (SOTI) to Children With IgE-mediated Wheat Allergy

This is an observational pilot study investigating the effectiveness, safety and specific immunological mechanisms of Specific Oral Tolerance Induction (SOTI) in children with IgE-mediated wheat allergy. The study will include 10 patients with persistent IgE-mediated allergy to wheat, who will undergo 1-year home SOTI. Moreover, 5 patients with IgE-mediated allergy …

2 - 16 years of age All Phase N/A
Y Yiorgos A. Bobetsis

Comparison of the Effectiveness of Two Different Surgical Therapeutic Protocols of Peri-implantitis

The purpose of the present study is to compare the 1-year clinical, radiographic and microbiological outcomes and patients' satisfaction following surgical treatment of peri-implantitis after applying two different surface modification methods. Secondarily, analysis and comparison of the microbiological results of implants diagnosed and treated for peri-implantitis with healthy implants will …

18 - 80 years of age All Phase N/A
P Panagiotis Chatzistavridis, MD, MSc

Evaluation of the Stress Response in Bariatric Surgery With and Without the Use of Opioids

The goal of this clinical trial is to compare Opioid Free and Opioid Based Anaesthesia in patients undergoing sleeve gastrectomy. The main questions it aims to answer are: Will the total dose of intraoperative opioid be reduced? Will there be difference in pain scores between groups? Participants will be managed …

18 - 75 years of age All Phase N/A
C Christos Psarrakis, MD

Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome

The PRECISION is a proof-of-concept, phase II randomized clinical trial aiming to evaluate the efficacy and safety of anakinra in patients with Post-Acute COVID Syndrome (PACS) of the pro-inflammatory respiratory phenotype. Improvement is measured by a composite endpoint, namely, the "Score of PACS progression reversal"

18 years of age All Phase 2/3

A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer

The purpose of this study is to describe the real-world patient and disease characteristics of metastatic non-small cell lung cancer (NSCLC) participants initiated on first-line (1L) treatment with nivolumab, ipilimumab, and platinum-based chemotherapy (NIVO/IPI/PBC), in the overall study population and the subpopulations per histological subtype of NSCLC and PD-L1 expression …

18 years of age All Phase N/A

Simplify language using AI